This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Allergan Inc (AGN)

NYSE: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 988.70M 1.10B 938.10M 4.90M
Operating Gains/Losses 417.40M 5.70M 5.90M 15.50M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -139.60M -34.30M -105.60M -71.40M
(Increase) Decrease in Inventories -26.90M -7.30M -24.00M -5.60M
(Increase) Decrease In Other Current Assets -800.00K -16.00M -33.10M -11.30M
(Decrease) Increase In Payables 37.40M 32.70M -19.30M 8.60M
(Decrease) Increase In Other Current Liabilities 175.10M 125.50M 19.30M 11.70M
(Increase) Decrease In Other Working Capital 1.60M 70.80M 200.00K 0.00
Other Non-Cash Items 191.90M 157.80M 107.50M 476.40M
Net Cash From Continuing Operations 1.70B 1.60B 1.08B 463.90M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.70B 1.60B 1.08B 463.90M
Sale of Property, Plant & Equipment 500.00K 1.80M 1.20M 400.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 683.20M 784.60M 1.14B 75.00M
Purchases of Property, Plant & Equipment -184.00M -161.30M -130.10M -157.00M
Acquisitions -849.40M -349.20M -101.40M -69.80M
Purchases of Short-Term Investments -1.03B -865.20M -571.10M -824.10M
Other Cash from Investing Activities 0.00 0.00 0.00 -1.70M
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.38B -589.30M 340.80M -977.20M
Issuance of Debt 598.50M 0.00 0.00 648.00M
Cash Used for Financing Activities
Issuance of Capital Stock 179.30M 246.40M 264.00M 234.00M
Repayment of Long-Term Debt 0.00 0.00 -808.90M 0.00
Repurchase of Capital Stock -650.70M -909.00M -461.70M -286.00M
Payment of Cash Dividends -77.40M -60.40M -61.10M -60.60M
Other Financing Charges, Net -21.50M 5.50M 65.40M 27.60M
Net Cash From Financing Activities 28.20M -717.50M -1.00B 563.00M
Effect of Exchange Rate Changes -4.00M 2.60M -5.50M -5.60M
Net Change in Cash & Cash Equivalents 344.30M 295.70M 414.90M 44.10M
AGN News

Analysts Ratings for AGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 6 6 9
Moderate Buy 0 0 0 0
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
GET AGN ANALYST REPORT

Brokerage Partners

AGN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs